Impact of food administration on lopinavir–ritonavir bioequivalence studies

HIV-1 Protease Inhibitors Are Substrates for the<i>MDR</i>1 Multidrug Transporter

Caroline Lee, Michael M. Gottesman, Carol Cardarelli et al. · Biochemistry · 1998 · 481 citations

Protease Inhibitors, Biochemistry, Medicine +14

Characterization of Fluids from the Stomach and Proximal Jejunum in Men and Women

Anders Lindahl, Anna‐Lena Ungell, Lars Knutson et al. · Pharmaceutical Research · 1997 · 402 citations

Interindividual variation in expression of P-glycoprotein in normal human liver and secondary hepatic neoplasms.

Erin G. Schuetz, Kishio Furuya, John D. Schuetz · Journal of Pharmacology and Experimental Therapeutics · 1995 · 263 citations

The Tablet Formulation of Lopinavir/Ritonavir Provides Similar Bioavailability to the Soft-Gelatin Capsule Formulation With Less Pharmacokinetic Variability and Diminished Food Effect

Cheri E. Klein, Yi‐Lin Chiu, Walid M. Awni et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2007 · 151 citations

Diminished Food Effect, Pharmaceutical Science, Ritonavir Exposures +13

P-glycoprotein and MRP1 expression and reduced ritonavir and saquinavir accumulation in HIV-infected individuals

E. Rhiannon Meaden · Journal of Antimicrobial Chemotherapy · 2002 · 111 citations · Full text